ArticleExperimental hematology & oncology2026

Inhibition of protein kinase CK2 remodels the tumor immune microenvironment and sensitizes lung cancer to PD-L1 blockade.

Sijia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.